Enclosing the Audited Financial Results for the year ended 31.03.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Citichem India Ltd reported audited standalone financial results for FY25 (year ended 31 March 2025). Total revenue from operations rose to ₹3,567.89 lakhs from ₹3,151.16 lakhs in FY24, a growth of roughly 13%. Profit before tax improved to about ₹881.81 lakhs versus ₹728.57 lakhs in the previous year, an increase of around 21%. The company's balance sheet strengthened significantly, with share capital rising to ₹680 lakhs (from ₹500 lakhs) and reserves & surplus jumping to ₹1,331.41 lakhs (from ₹252.04 lakhs). Long-term borrowings declined to ₹61.78 lakhs from ₹108.20 lakhs, keeping the debt-equity ratio very low. The auditors (NGST & Associates) issued an unmodified (clean) opinion on the financial results, and no going-concern or qualification issues were raised.
A clean audit with moderate revenue growth, strong profit growth, and a much stronger balance sheet is broadly positive for shareholders. The company appears financially healthy, though the revenue growth of ~13% falls short of standout territory, so the stock may see only a mildly positive reaction.